The annual impact of seasonal influenza in the US: Measuring disease burden and costs-Reference-Cited by-同舟云学术

The annual impact of seasonal influenza in the US: Measuring disease burden and costs

Published:2007-06 Issue:27 Volume:25 Page:5086-5096
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Molinari Noelle-Angelique M.,Ortega-Sanchez Ismael R.,Messonnier Mark L.,Thompson William W.,Wortley Pascale M.,Weintraub Eric,Bridges Carolyn B.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference54 articles.

1. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP);Centers for Disease Control and Prevention;MMWR,2006

2. The economic impact of pandemic influenza in the United States: priorities for intervention;Meltzer;Emerg Infect Dis,1999

3. Systematic review and economic decision modelling for the prevention and treatment of influenza A and B;Turner;Health Technol Assess,2003

4. An intranasal influenza vaccine for the prevention of influenza in healthy children was cost effective;Schwartz;Evid Based Med,2002

5. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: a randomized controlled trial;Bridges;JAMA,2000

Cited by 1385 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-effectiveness of recombinant influenza vaccine compared with standard dose influenza vaccine in adults 18–64 years of age;Vaccine;2024-10

2. Deep Generative Optimization of mRNA Codon Sequences for Enhanced Protein Production and Therapeutic Efficacy;2024-09-08

3. Infectious Disease Updates for Primary Care;Medical Clinics of North America;2024-09

4. Expression and purification of an NP-hoc fusion protein: Utilizing influenza a nucleoprotein and phage T4 hoc protein;Protein Expression and Purification;2024-09

5. Safety, reactogenicity and immunogenicity of an intranasal seasonal influenza vaccine adjuvanted with gram-positive matrix (GEM) particles (FluGEM): A randomized, double-blind, controlled, ascending dose study in healthy adults and elderly;Vaccine;2024-09